Nimotop(R) (nimodipine) 30-mg Capsules
Bayer HealthCare

Contact Us Sitemap
Home Why Nimotop? 21-Day Therapy About SAH Resources Prescribing Information Safety Information
Bayer Links


Contact Us

Do you have questions, comments or concerns you wish to share with Bayer HealthCare Pharmaceuticals? Please click below for contact information, and our easy-to-use Contact Form.

Request For Medical Information

To email requests for medical information on Nimotop, click here

For live responses to medical information inquiries on Nimotop please call 1-800-288-8371 during working hours, Monday to Friday, between the hours of 9 AM and 5 PM EST.

Visit the Bayer HealthCare Pharmaceuticals Web Site Contact Page




DO NOT ADMINISTER NIMOTOP INTRAVENOUSLY OR BY OTHER PARENTERAL ROUTES. DEATHS AND SERIOUS, LIFE-THREATENING ADVERSE EVENTS HAVE OCCURRED WHEN THE CONTENTS OF NIMOTOP CAPSULES HAVE BEEN INJECTED PARENTERALLY

(See WARNINGS and DOSAGE AND ADMINISTRATION.)


 
  • In patients with SAH, Nimotop® controls damage with a low side effect profile.

  • Decreased blood pressure is the most common side effect, occurring in 4.4% of patients. Blood pressure should be monitored during therapy.1

  • Other side effects occurring at a low frequency of ≥1.0% include headache, nausea, and bradycardia.1

  • No clinically significant effects on hematologic factors, renal or hepatic function, or carbohydrate metabolism have been causally associated with oral nimodipine.1

  • Nimotop® does not appear to affect anesthetic management.2
 
Sources:
  1. Nimotop® (nimodipine) Capsules Prescribing Information December 2005

  2. Stullken EH, Johnston WE, Prough DS. Implications of nimodipine prophylaxis of cerebral vasospasm on anesthetic management during intracranial aneurysm clipping. J. Neurosurg. 1985; 62:200-205.



© Bayer HealthCare Pharmaceuticals.

Bayer HealthCare Pharmaceuticals
6 West Belt
Wayne, NJ 07470

The information provided on Bayer products is only intended for the United States audience. Regulatory requirements, regulations, laws, and distribution of information about drug products may vary from country to country. Product names and indications (product uses) also may be different in different countries. The prescribing information provided here is based on United States labeling and may not be appropriate outside of the US.